Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer

Background: It was a difficult question to identify candidates who would benefit most from adjuvant chemotherapy in stage II colon cancer because of the paucity of relevant conclusive clinical trial results. We aimed to assess if mucinous adenocarcinoma (MUA) could be an indicator for the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong, Ge, Kuanxue, Fu, Guangshun, Chu, Junfeng, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290047/
https://www.ncbi.nlm.nih.gov/pubmed/32582726
http://dx.doi.org/10.3389/fmed.2020.00205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290047/
https://www.ncbi.nlm.nih.gov/pubmed/32582726
http://dx.doi.org/10.3389/fmed.2020.00205

Ejemplares similares